Curcumin inhibits cell proliferation and induces apoptosis of human non-small cell lung cancer cells through the upregulation of miR-192-5p and suppression of PI3K/Akt signaling pathway

Jin,Hai; Qiao,Fan; Wang,Yan; Xu,Yongdong; Shang,Yan

doi:10.3892/or.2015.4258

Curcumin inhibits cell proliferation and induces apoptosis of human non-small cell lung cancer cells through the upregulation of miR-192-5p and suppression of PI3K/Akt signaling pathway

Authors:
- Hai Jin
- Fan Qiao
- Yan Wang
- Yongdong Xu
- Yan Shang
View Affiliations

Affiliations: Department of Cardiothoracic Surgery, Changhai Hospital, Second Military Medical University, Shanghai 200433, P.R. China, Center Laboratory, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai 201399, P.R. China, Department of Thoracic Surgery, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai 201399, P.R. China, Department of Respiratory Medicine, Changhai Hospital, Second Military Medical University, Shanghai 200433, P.R. China
Published online on: September 8, 2015 https://doi.org/10.3892/or.2015.4258
Pages: 2782-2789

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Curcumin is the main active ingredient extracted from the traditional Chinese medicine, turmeric, which acts against non-small cell lung cancer cell (NSCLC), lowers blood pressure, is anti-inflammatory, choleretic, and exerts anti‑oxidant effects, without any obvious toxicity in the long term. The aim of the present study was to investigate whether the anticancer effect of curcumin inhibited cell proliferation and induced apoptosis of human NSCLC through the upregulation of microRNA‑192-5p (miR-192-5p) and suppression of the PI3K/Akt signaling pathway. In the present study, treatment with curcumin inhibited cell proliferation, induced cell apoptosis and increased the caspase-3 activity of A549 cells. The results also showed that, miR-192-5p relative expression of NCL-H460 cells was relatively lower than that of A549 cells, which was higher, with that of BEAS-2E cells being the highest. miR-192-5p mimics suppressed cell proliferation and increased cell apoptosis of A549 cells. However, anti-miR-192-5p mimics increased cell proliferation and inhibited cell apoptosis of A549 cells. Curcumin treatment effectively increased the relative miR‑192-5p expression and suppressed the PI3K/Akt signaling pathway. miR-192-5p mimics enhanced the effect of curcumin on cell viability and apoptosis and suppressed the PI3K/Akt signaling pathway in A549 cells. Anti-miR-192-5p mimics reversed the effect of curcumin on A549 cells and PI3K/Akt expression. Collectively, our findings suggested that curcumin inhibited cell proliferation and induced apoptosis of human non-small cell lung cancer cells through the upregulation of miR-192-5p and suppression of the PI3K/Akt signaling pathway.

View Figures

View References

1	Kwon SB, Kim MJ, Ham SY, Park GW, Choi KD, Jung SH and Yoon DY: H9 induces apoptosis via the intrinsic pathway in non-small-cell lung cancer A549 cells. J Microbiol Biotechnol. 25:343–352. 2015. View Article : Google Scholar : PubMed/NCBI
2	Kogita A, Togashi Y, Hayashi H, Sogabe S, Terashima M, De Velasco MA, Sakai K, Fujita Y, Tomida S, Takeyama Y, et al: Hypoxia induces resistance to ALK inhibitors in the H3122 non-small cell lung cancer cell line with an ALK rearrangement via epithelial-mesenchymal transition. Int J Oncol. 45:1430–1436. 2014.PubMed/NCBI
3	Lønvik K, Sørbye SW, Nilsen MN and Paulssen RH: Prognostic value of the MicroRNA regulators Dicer and Drosha in non-small-cell lung cancer: Co-expression of Drosha and miR-126 predicts poor survival. BMC Clin Pathol. 14:452014. View Article : Google Scholar : PubMed/NCBI
4	Nana-Sinkam SP and Geraci MW: MicroRNA in lung cancer. J Thorac Oncol. 1:929–931. 2006. View Article : Google Scholar
5	Garofalo M, Quintavalle C, Di Leva G, Zanca C, Romano G, Taccioli C, Liu CG, Croce CM and Condorelli G: MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer. Oncogene. 27:3845–3855. 2008. View Article : Google Scholar : PubMed/NCBI
6	Zhou L, Luan H, Liu Q, Jiang T, Liang H, Dong X and Shang H: Activation of PI3K/Akt and ERK signaling pathways antagonized sinomenine-induced lung cancer cell apoptosis. Mol Med Rep. 5:1256–1260. 2012.PubMed/NCBI
7	Zito CR, Jilaveanu LB, Anagnostou V, Rimm D, Bepler G, Maira SM, Hackl W, Camp R, Kluger HM and Chao HH: Multi-level targeting of the phosphatidylinositol-3-kinase pathway in non-small cell lung cancer cells. PLoS One. 7:e313312012. View Article : Google Scholar : PubMed/NCBI
8	Chen QY, Jiao DM, Wang LF, Wang L, Hu HZ, Song J, Yan J, Wu LJ and Shi JG: Curcumin inhibits proliferation-migration of NSCLC by steering crosstalk between a Wnt signaling pathway and an adherens junction via EGR-1. Mol Biosyst. 11:859–868. 2015. View Article : Google Scholar : PubMed/NCBI
9	Lu W, Jiang JP, Hu J, Wang J and Zheng MZ: Curcumin protects against lipopolysaccharide-induced vasoconstriction dysfunction via inhibition of thrombospondin-1 and transforming growth factor-β1. Exp Ther Med. 9:377–383. 2015.PubMed/NCBI
10	Tizabi Y, Hurley LL, Qualls Z and Akinfiresoye L: Relevance of the anti-inflammatory properties of curcumin in neurodegenerative diseases and depression. Molecules. 19:20864–20879. 2014. View Article : Google Scholar : PubMed/NCBI
11	Borra SK, Mahendra J, Gurumurthy P, Jayamathi, Iqbal SS and Mahendra L: Effect of curcumin against oxidation of biomolecules by hydroxyl radicals. J Clin Diagn Res. 8:CC01–CC05. 2014.PubMed/NCBI
12	Nahar PP, Slitt AL and Seeram NP: Anti-inflammatory effects of novel standardized solid lipid curcumin formulations. J Med Food. 18:786–792. 2014. View Article : Google Scholar : PubMed/NCBI
13	Ali MS, Pandit V, Jain M and Dhar KL: Mucoadhesive micropar-ticulate drug delivery system of curcumin against Helicobacter pylori infection: Design, development and optimization. J Adv Pharm Technol Res. 5:48–56. 2014. View Article : Google Scholar : PubMed/NCBI
14	Zhang T, Cui GB, Zhang J, Zhang F, Zhou YA, Jiang T and Li XF: Inhibition of PI3 kinases enhances the sensitivity of non-small cell lung cancer cells to ionizing radiation. Oncol Rep. 24:1683–1689. 2010.PubMed/NCBI
15	Li H, Xie L and Lai RS: Association of EGFR mutations with low BRCA1 gene expression in non-small cell lung cancer. Mol Clin Oncol. 1:195–199. 2013.PubMed/NCBI
16	Liu X, Sun K, Song A, Zhang X, Zhang X and He X: Curcumin inhibits proliferation of gastric cancer cells by impairing ATP-sensitive potassium channel opening. World J Surg Oncol. 12:3892014. View Article : Google Scholar : PubMed/NCBI
17	Ma J, Fang B, Zeng F, Pang H, Zhang J, Shi Y, Wu X, Cheng L, Ma C, Xia J, et al: Curcumin inhibits cell growth and invasion through up-regulation of miR-7 in pancreatic cancer cells. Toxicol Lett. 231:82–91. 2014. View Article : Google Scholar : PubMed/NCBI
18	Li M, Zhang Q, Wu L, Jia C, Shi F, Li S, Peng A, Zhang G, Song X and Wang C: Serum miR-499 as a novel diagnostic and prognostic biomarker in non-small cell lung cancer. Oncol Rep. 31:1961–1967. 2014.PubMed/NCBI
19	Pacurari M, Addison JB, Bondalapati N, Wan YW, Luo D, Qian Y, Castranova V, Ivanov AV and Guo NL: The microRNA-200 family targets multiple non-small cell lung cancer prognostic markers in H1299 cells and BEAS-2B cells. Int J Oncol. 43:548–560. 2013.PubMed/NCBI
20	Bandi N, Zbinden S, Gugger M, Arnold M, Kocher V, Hasan L, Kappeler A, Brunner T and Vassella E: miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer. Cancer Res. 69:5553–5559. 2009. View Article : Google Scholar : PubMed/NCBI
21	Ye M and Zhang J and Zhang J, Miao Q, Yao L and Zhang J: Curcumin promotes apoptosis by activating the p53-miR-192-5p/215-XIAP pathway in non-small cell lung cancer. Cancer Lett. 357:196–205. 2015. View Article : Google Scholar
22	Yue W, Wang X and Wang Y: The relationship between the PI3K/Akt/mTOR signal transduction pathway and non-small cell lung cancer. Zhongguo Fei Ai Za Zhi. 12:312–315. 2009.In Chinese. PubMed/NCBI
23	Baykara O, Tansarikaya M, Demirkaya A, Kaynak K, Tanju S, Toker A and Buyru N: Association of epidermal growth factor receptor and K-Ras mutations with smoking history in non-small cell lung cancer patients. Exp Ther Med. 5:495–498. 2013.PubMed/NCBI
24	Xu X, Qin J and Liu W: Curcumin inhibits the invasion of thyroid cancer cells via down-regulation of PI3K/Akt signaling pathway. Gene. 546:226–232. 2014. View Article : Google Scholar : PubMed/NCBI
25	Xu Y, Zhang J, Han J, Pan X, Cao Y, Guo H, Pan Y, An Y and Li X: Curcumin inhibits tumor proliferation induced by neutrophil elastase through the upregulation of α1-antitrypsin in lung cancer. Mol Oncol. 6:405–417. 2012. View Article : Google Scholar : PubMed/NCBI
26	Schee K, Lorenz S, Worren MM, Günther CC, Holden M, Hovig E, Fodstad O, Meza-Zepeda LA and Flatmark K: Deep Sequencing the MicroRNA Transcriptome in Colorectal Cancer. PLoS One. 8:e661652013. View Article : Google Scholar : PubMed/NCBI